CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Open-market sale EVP, GC & Corporate Secretary sold 5,450 shares at $651.60 ($3,551,220)
- 4 Exercise or conversion President and CEO acquired 183 shares (option exercise)
- 4 Exercise or conversion EVP, CFO and Treasurer acquired 1,849 shares (option exercise)
- 4 Open-market sale Executive Vice President sold 7,143 shares at an average $630.43 ($4,503,163)
- 4 Open-market sale President and CEO sold 29,260 shares at an average $631.98 ($18,491,642)
- 4 Open-market sale Executive Vice President sold 8,411 shares at an average $627.74 ($5,279,893)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Executive Vice President gave up 1,499 shares (to pay taxes)
- 4 Open-market sale Director sold 2,306 shares at an average $512.97 ($1,182,917)
- 4 Open-market sale Director sold 2,683 shares at $506.41 ($1,358,697)
- 4 Open-market sale Director sold 1,279 shares at $491.34 ($628,425)
- 4 Exercise or conversion Director acquired 262 shares (option exercise)
- 4 Exercise or conversion Director acquired 262 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 346 shares (option exercise)
- 4 Exercise or conversion Director acquired 262 shares (option exercise)
- 4 Exercise or conversion Director acquired 262 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 4 of 74 · 1,467 filings